Orphan Drug Designation For Remdesivir Is 'Consistent' With Precedent, Former FDA Lawyer Says

 
• By Brenda Sandburg
Vaccine bottle design related to viruses cures. Illustration design medical healing.
Gilead's remdesivir receives orphan drug designation for COVID-19

More from US FDA

More from Agency Leadership